Basics Lantheus Holdings, Inc. Lantheus Holdings Inc develops diagnostic products for the healthcare sector. Its chief product is imaging agents used by physicians in diagnostic procedures such as cardiac ultrasounds and X-ray imaging. IPO Date: June 25, 2015 Sector: Healthcare Industry: Medical Diagnostics and Research Market Cap: $4.2B Activated in VL: True Average Daily Range Avg Daily Range: $0.77 | 2.30% Avg Daily Range (30 D): $1.33 | 2.36% Avg Daily Range (90 D): $1.13 | 2.04% Institutional Daily Volume Avg Daily Volume: .58M Avg Daily Volume (30 D): .98M Avg Daily Volume (90 D): 1.36M Trade Size Avg Trade Size (Sh.): 65 Avg Trade Size (Sh.) (30 D): 47 Avg Trade Size (Sh.) (90 D): 56 Institutional Trades Total Inst.Trades: 5,646 Avg Inst. Trade: $3.36M Avg Inst. Trade (30 D): $3.78M Avg Inst. Trade (90 D): $4.71M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $5.69M Avg Closing Trade (30 D): $8.24M Avg Closing Trade (90 D): $9.3M Avg Closing Volume: 104.53K     News Nov 13, 2025 @ 10:40 PM Bragar Eagel & Squire is Investigating Certain Off... Source: Bragar Eagel & Squire, P.C. Nov 9, 2025 @ 1:50 PM LNTH SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi,... Source: Faruqi & Faruqi, Llp Nov 8, 2025 @ 3:37 PM LANTHEUS CLASS ACTION DEADLINE: Bragar Eagel & Squ... Source: Bragar Eagel & Squire, P.C. Nov 6, 2025 @ 7:50 PM LANTHEUS DEADLINE: ROSEN, A TOP RANKED LAW FIRM, E... Source: Rosen Law Firm Nov 2, 2025 @ 10:27 PM LNTH DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, En... Source: Rosen Law Firm Financials   TTM Q3 2025 Q2 2025 Basic EPS $2.46 $.41 $1.15 Diluted EPS $2.41 $.41 $1.12 Revenue $ 1.53B $ 384.01M $ 378.05M Gross Profit $ 949.62M $ 222.37M $ 241.01M Net Income / Loss $ 167.68M $ 27.77M $ 78.76M Operating Income / Loss $ 347.52M $ 43.62M $ 87.97M Cost of Revenue $ 576.31M $ 161.65M $ 137.03M Net Cash Flow $ -484.35M $ -313.56M $ -242.95M PE Ratio 26.07